Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-9255
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity ; volume:8 ; number:1 ; day:4 ; month:11 ; year:2011 ; pages:1-7 ; date:12.2011
Journal of Inflammation ; 8, Heft 1 (4.11.2011), 1-7, 12.2011
- Urheber
-
Koobkokkruad, Thongchai
- Beteiligte Personen und Organisationen
-
Kadotani, Tatsuya
Hutamekalin, Pilaiwanwadee
Mizutani, Nobuaki
Yoshino, Shin
SpringerLink (Online service)
- DOI
-
10.1186/1476-9255-8-31
- URN
-
urn:nbn:de:1111-2016073033869
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koobkokkruad, Thongchai
- Kadotani, Tatsuya
- Hutamekalin, Pilaiwanwadee
- Mizutani, Nobuaki
- Yoshino, Shin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Monoclonal antibodies against the fifth component of human complement
Monoclonal antibodies
High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Novel haptens and monoclonal antibodies with subnanomolar affinity for a classical analytical target, ochratoxin A
Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis
Clinical relevance of new monoclonal antibodies
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies against the fifth component of human complement
Monoclonal antibodies
High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Novel haptens and monoclonal antibodies with subnanomolar affinity for a classical analytical target, ochratoxin A
Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis
Clinical relevance of new monoclonal antibodies
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies against the fifth component of human complement
Monoclonal antibodies
High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens
Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Novel haptens and monoclonal antibodies with subnanomolar affinity for a classical analytical target, ochratoxin A
Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis
Clinical relevance of new monoclonal antibodies